Why is brain tumor research for older adults lagging behind? A new analysis reveals a critical gap.

If you're an older adult diagnosed with a brain tumor called glioma, the research guiding your care has a major blind spot. These tumors behave differently and are more aggressive in older people, yet the scientific world has been slow to catch up. A new analysis of over 1,200 studies shows that while research has grown more than fourfold since 2001, it's still not enough. The work is led by a few countries like the U.S., Italy, and Germany, and has evolved from basic classification to standardizing treatments like radiation and chemotherapy. More recently, scientists have started looking at the tumor's molecular details, like a specific genetic marker called MGMT methylation. However, the analysis reveals persistent and significant gaps. We don't know enough about how common age-related health problems interact with these tumors or how to account for the unique biology in older patients. While clinical trials have set up basic treatment frameworks, the future needs to bring together cancer specialists and geriatric experts. The dominance of Western institutions also means we're missing crucial perspectives from other rapidly aging nations around the world.